期刊文献+

脑膜瘤磁共振波谱Cho/Cr比值与Ki-67核抗原表达的相关性研究 被引量:1

Correlation study between Cho/Cr value of MRS and Ki-67 labeling index in meningiomas
下载PDF
导出
摘要 目的:探讨良、恶性脑膜瘤磁共振波谱(1H-MRS)Cho/Cr比值与Ki-67核抗原表达的相关性。方法:经手术病理证实的36例脑膜瘤在治疗前行常规MRI及1H-MRS检查(脑膜瘤I级30例,Ⅱ+Ⅲ级6例)。1H-MRS检查包括PRESS35、PRESS144序列。结果:良性脑膜瘤组Cho/Cr比值3.80±1.08;恶性脑膜瘤组为7.22±0.70。差异具有显著性(t=7.40,P=0.000)。良性脑膜瘤组Ki-67积分光密度6.43±1.09;恶性脑膜瘤组为12.15±4.14。相关性分析表明,Ki-67表达与Cho/Cr呈显著正相关(r=0.832,P=0.000)。MRS表现:本组脑膜瘤病例Cho峰升高,Cr降低。结论:脑膜瘤MRSCho/Cr比值与Ki-67表达具有相关性,是预测肿瘤增殖活性的有价值的指标,有助于脑膜瘤病理分级。 Objective: To investigate the correlation between Cho/Cr value of 'H magnetic resonance spectroscopy(1H-MRS) and the Ki-67 labeling index in meningiomas. Methods: Thirty-six patients with meningioma underwent conventional MR and 1H-MRS before operation (Grade Ⅰ 30 cases; Grade Ⅱ+Ⅲ 6 cases). 1H-MRS sequences included PRESS 35, PRESS 144. Expression of Ki-67 nuclear antigen were detected by immunohistochemical method of streptavidin-biotin-peroxidase(SP). Results: The mean Cho/Cr ratio in the benign and malignant groups were 3.80±1.08 and 7.22±0.70, respectively(t=7.40, P=0.000). Ki- 67 in the benign and malignant groups were 6.43±1.09 and 12.15±4.14, respectively. A significant linear correlation was observed between the Cho/Cr ratio and the expression of Ki-67. The MRS features of meningiomas were as follow: Cho increased markedly, Cr decreased evidently. Conclusion:1H-MRS is a useful diagnostic method for determining the proliferation or malignant potential of meningiomas according to the Cho/Cr ratio and the latter is correlated to the Ki-67 value.
出处 《中国临床医学影像杂志》 CAS 北大核心 2008年第12期855-857,868,共4页 Journal of China Clinic Medical Imaging
关键词 脑膜瘤 KI-67抗原 磁共振波谱学 Meningioma Ki-67 antigen Magnetic resonance spectroscopy
  • 相关文献

参考文献13

  • 1Leclerc X, Huisman TA, Sorensen AG. The potential of proton magnetic resonance spectroscopy (^1H-MRS) in the diagnosis and management of patients with brain tumors [J]. Curt Opin Oncol, 2002, 14(3):292-298.
  • 2Terzi A, Saglam EA, Barak A, et al. The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays [J]. Pathol Res Pract, 2008, 204(5):305-314.
  • 3Servo A, Porras M, Jaaskelainen J, et al. Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones[J]. Neuroradiology, 1990, 32(2):94-97.
  • 4Fountas KN. In vivo proton magnetic resonance spectroscopy of brain tumors[J]. Stereotact Funct Neurosurg, 2000, 74(2):83-94.
  • 5Shimizu H, Kumabe T, Shirane R, et al. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas[J]. AJNR, 2000, 21(4):659-665.
  • 6Glunde K, Jacobs MA, Bhujwalla ZM. Choline metabolism in cancer: implications for diagnosis and therapy[J]. Expert Rev Mol Diagn, 2006, 6(6):821-829.
  • 7Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy[J]. NMR Biomed, 1997, 10(1):2-12.
  • 8Manton DJ, Lowry M, Blackband SJ, et al. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumors [J]. NMR Biomed, 1995, 8(3): 104-112.
  • 9Fayed N, Davila J, Medrano J, et al. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI [J]. Eur J Radiol, 2008, 67 (3):427- 433.
  • 10Takeuchi H, Kubota T, Kabuto M, et al. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear and Ki-67 immunohistochemical study [J]. Surg Neurol, 1997, 48(5):501.

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部